EZH2 and cancer: Enhancer of zeste homolog 2 (EZH2) and HDACs were recently identified as critical histone modifiers of deregulated miRNAs in cancer and can be recruited to a miRNA promoter by transcription factors such as v-myc avian myelocytomatosis viral oncogene homolog (MYC) [28].